Zinc bound to the killer cell-inhibitory receptor modulates the negative signal in human NK cells

Journal of Immunology

Volumn 161, Issue 3, 1998, Pages 1299-1305

  Rajagopalan, Sumati ^a   Long, Eric O ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZINC;

AMINO TERMINAL SEQUENCE; ARTICLE; CYTOTOXICITY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TARGET CELL;

BINDING SITES; CELL LINE; DOWN-REGULATION; HISTIDINE; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; PEPTIDE FRAGMENTS; PEPTIDES; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; ZINC;

EID: 0032146232     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. + IL-2-activated NK cells. Nature 358:66.
2. Moretta, A., M. Vitale, C. Bottino, A. M. Orengo, L. Morelli, R. Augugliaro, M. Barbaresi, E. Ciccone, and L. Moretta. 1993. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells: anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 178:597.
3. Lanier, L. L. 1997. Natural killer cells: from no receptors to too many. Immunity 6:371.
4. Wagtmann, N., S. Rajagopalan, C. C. Winter, M. Peruzzi, and E. O. Long. 1995. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3:801.
5. Burshtyn, D. N., A. M. Scharenberg, N. Wagtmann, S. Rajagopalan, K. Berrada, T. Yi, J. P. Kinet, and E. O. Long. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4:77.
6. Yokoyama, W. M., and W. E. Seaman. 1993. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on NK cells: the NK gene complex. Annu. Rev. Immunol. 11:613.
7. Lazetic, S., C. Chang, J. P. Houchins, L. L. Lanier, and J. H. Phillips. 1996. Human NK cell receptors involved in MHC class I recognition are disulfide- linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 157:4741.
8. Brooks, A. G., P. E. Posch, C. J. Scorzelli, F. Borrego, and J. E. Coligan. 1997. NKG2A complexed with CD94 defines a novel inhibitory NK cell receptor. J. Exp. Med. 185:795.
9. Carretero, M., C. Cantoni, T. Bellón, C. Bottino, R. Biassoni, A. Rodríguez, J. J. Pérez-Villar, L. Moretta, A. Moretta, and M. Lopez-Botet. 1997. The CD94 and NKG2-A C-type lectins covalently assemble to form a NK cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 27:563.
10. Houchins, J. P., L. L. Lanier, E. C. Niemi, J. H. Phillips, and J. C. Ryan. 1997. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. Immunol. 158:3603.
11. Braud, V. M., D. S. J. Allan, C. A. O'Callaghan, K. Söderström, A. D'Andrea, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, L. L. Lanier, and A. J. McMichael. 1998. HLA-E binds to NK cell receptors CD94/NKG2A, B and C. Nature 391:795.
12. Borrego, F., M. Ulbrecht, E. H. Weiss, J. E. Coligan, and A. G. Brooks. 1998. Recognition of HLA-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from NK cell mediated lysis, J. Exp. Med. 187:813.
13. Rajagopalan, S., C. C. Winter, N. Wagtmann, and E. O. Long. 1995. The Ig- related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells. J. Immunol. 155:4143.
14. Colonna, M., G. Borsellino, M. Falco, G. B. Ferrara, and J. L. Strominger. 1993. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific NK cells. Proc. Natl. Acad. Sci. USA 90:12000.
15. Biassoni, R., M. Falco, A. Cambiaggi, P. Costa, S. Verdiani, D. Pende, R. Conte, C. Di Donate, P. Parham, and L. Moretta. 1995. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules: role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J. Exp. Med. 182:605.
16. Mandelboim, O., H. T. Reyburn, M. Valés-Gómez, L. Pazmany, M. Colonna, G. Borsellino, and J. L. Strominger. 1996. Protection from lysis by NK cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J. Exp. Med. 184:913.
17. Jongeneel, C. V., J. Bouvier, and A. Bairoch. 1989. A unique signature identifies a family of zinc-dependent metallopeptidases. FEBS Lett. 242:211.
18. Vallee, B. L., and D. S. Auld. 1990. Zinc coordination, function, and structure of zinc enzymes and other proteins. Biochemistry 29:5647.
19. Fraser, J. D., R. G. Urban, J. L. Strominger, and H. Robinson. 1992. Zinc regulates the function of two superantigens. Proc. Natl. Acad. Sci. USA 89:5507.
20. Somers, W., M. Ultsch, A. M. De Vos, and A. A. Kossiakoff. 1994. The X-ray structure of a growth hormone-prolactin receptor complex. Nature 372:478.
21. Fan, Q. R., D. N. Garboczi, C. C. Winter, N. Wagtmann, E. O. Long, and D. C. Wiley. 1996. Direct binding of a soluble NK cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. Proc. Natl. Acad. Sci. USA 93:7178.
22. Berg, J. M., and Y. G. Shi. 1996. The galvanization of biology: a growing appreciation for the roles of zinc. Science 271:1081.
23. Frankel, A. D., L. Chen, R. J. Cotter, and C. O. Pabo. 1988. Dimerization of the tat protein from human immunodeficiency virus: a cysteine-rich peptide mimics the normal metal-linked dimer interface. Proc. Natl. Acad. Sci. USA 85:6297.
24. Cunningham, B. C., M. G. Mulkerrin, and J. A. Wells. 1991. Dimerization of human growth hormone by zinc. Science 253:545.
25. Gong, J. H., G. Maki, and H. G. Klingemann. 1994. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated NK cells. Leukemia 8:652.
26. Rajagopalan, S., and E. O. Long. 1997. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J. Exp. Med. 185:1523.
27. Mizuno, S., S. H. Kang, H. W. Lee, J. A. Trapani, B. Dupont, and S. Y. Yang. 1989. Isolation and expression of a cDNA clone encoding HLA-Cw6: unique characteristics of HLA-C encoded gene products. Immunogenetics 29:323.
28. Melero, I., A. Salmeron, M. A. Balboa, J. Aramburu, and M. Lopez-Botet. 1994. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes. J. Immunol. 152:1662.
29. Wagtmann, N., R. Biassoni, C. Cantoni, S. Verdiani, M. Malnati, M. Vitale, C. Bottino, L. Moretta, A. Moretta, and E. O. Long. 1995. Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intracellular domains. Immunity 2:439.
30. Earl, P. L., and B. Moss. 1988. Generation of recombinant vaccinia viruses. In Current Protocols in Molecular Biology. F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, eds. John Wiley & Sons, New York, p. 16.17.1.
31. Malnati, M. S., P. Lusso, E. Ciccone, A. Moretta, L. Moretta, and E. O. Long. 1993. Recognition of virus-infected cells by NK cell clones is controlled by polymorphic target cell elements. J. Exp. Med. 178:961.
32. Peruzzi, M., N. Wagtmann, and E. O. Long. 1996. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J. Exp. Med. 184:1585.
33. Fan, Q. R., L. Mosyak, C. C. Winter, N. Wagtmann, E. O. Long, and D. C. Wiley. 1997. Structure of the inhibitory receptor for human NK cells resembles haematopoietic receptors. Nature 389:96.
34. Ross, G. M., I. L. Shamovsky, G. Lawrance, M. Sole, S. M. Dostaler, S. L. Jimmo, D. F. Weaver, and R. J. Riopelle. 1997. Zinc alters conformation and inhibits biological activities of nerve growth factor and related neurotrophins. Nat. Med. 3:872.
35. Bléry, M., J. Delon, A. Trautmann, A. Cambiaggi, L. Olcese, R. Biassoni, L. Moretta, P. Chavrier, A. Moretta, M. Daëron, and E. Vivier. 1997. Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine- based activation motifs. J. Biol. Chem. 272:8989.
36. Heldin, C. H. 1995. Dimerization of cell surface receptors in signal transduction. Cell 80:213.
37. Zheng, R. L., T. M. Jenkins, and R. Craigie. 1996. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc. Natl. Acad. Sci. USA 93:13659.